1 asset in Progressive Muscular Dystrophy
Therapeutic assets addressing Progressive Muscular Dystrophy, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Elranatamab Progressive Muscular Dystrophy | M.D. Anderson Cancer Center | P2 | CCC (53) |